Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 3Phase NA 1Phase 4 1

Status

Completed 29Unknown 8Terminated 7Recruiting 7Active not recruiting 3

Sponsor Class

OTHER 5NIH 1NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Lymphoid 3Gynecologic 2

Conditions

Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Hodgkin Disease 2Teratoma 1Ovarian Germ Cell Cancer 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Bleomycin × Clear all
NCT05675410 2026-05-27

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

National Cancer Institute (NCI)

Phase 3 Recruiting
1,875 enrolled
Lymphoid

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT04685616 2026-03-30

RADAR

University College, London

Phase 3 Recruiting
1,042 enrolled
Lymphoid

Hodgkin Disease

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting
500 enrolled

Neoplasms, Germ Cell and Embryonal

NCT04638790 2024-09-27

HL-Russia-1

State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia

Phase 3 Recruiting
300 enrolled
Lymphoid

Hodgkin Disease

NCT02429687 2023-04-25

MOGCT-01

Shandong University

Phase 3 Recruiting
129 enrolled
Gynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms

NCT02429700 2023-04-25

SCST-01

Shandong University

Phase 3 Recruiting
132 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡